Skip to main content
SpringerLink
Log in

Opioid-associated central sleep apnea: a case series

  • Case Report
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Introduction

Subjects on methadone maintenance for drug addiction have been reported to have central sleep apnea (CSA). However, there are few reports of disordered breathing in patients receiving opioids for chronic pain.

Materials and methods

We report on six patients (ages 41–68, two females, body mass index 27–34, morphine equivalent doses 120–420 mg/day, Epworth Scales 7–21) referred to our sleep center receiving sustained release opioids for more than 6 months with excessive daytime sleepiness. CSA was defined as apnea–hypopnea index (AHI) more than 5 per hour with ≥50% central events. Bilevel (BLV) titration was done to determine settings and all patients were followed for at least 6 months on nocturnal BLV. AHI ranged 28.4–106 per hour. Time less than 90% O2 saturation ranged 1.8 min to 6.4 h. Four of the patients were treated with chronic BLV ventilation with settings ranging 12–16 cm H2O (inspiratory positive airway pressure)/4–8 cm H2O (expiratory positive airway pressure) with backup rate of 12–16. Among the four patients who used BLV treatment for at least 6 months, Epworth scores improved (by 4, 12, 5, and 9, respectively).

Conclusion

Treatment of opioid-associated CSA with BLV corrected nocturnal hypoxemia and reduced sleep fragmentation. Randomized controlled trials, with objective measures of daytime function, are recommended in opioid-induced CSA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lanfranchi PA, Braghiroli A, Bosimini E (1999) Prognostic value of nocturnal Cheyne–Stokes respiration in chronic heart failure. Circulation 99:1435–1440

    PubMed  CAS  Google Scholar 

  2. Bradley TD, Floras JS (2003) Sleep apnea and heart failure: part II: central sleep apnea. Circulation 107:1822–1826 doi:10.1161/01.CIR.0000061758.05044.64

    Article  PubMed  Google Scholar 

  3. Wang D, Teichtahl H, Drummer O (2005) Central sleep apnea in stable methadone maintenance treatment patients. Chest 128:1348–1356 doi:10.1378/chest.128.3.1348

    Article  PubMed  Google Scholar 

  4. Walker JM, Farney RJ, Rhondeau SM (2007) Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 3:455–461

    PubMed  Google Scholar 

  5. Novak S, Nemeth WC, Lawson KA (2004) Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 5:59–65 doi:10.1111/j.1526-4637.2004.04001.x

    Article  PubMed  Google Scholar 

  6. ARCOS US Department of Justice, Drug Enforcement Administration, Office of Diversion Control (2008) Retail drug summary. http://www.deadiversion.usdoj.gov/arcos/retail_drug_summary

  7. Ballantyne JC, Mao J (2003) Opioid therapy for chronic pain. N Engl J Med 349:1943–1953 doi:10.1056/NEJMra025411

    Article  PubMed  CAS  Google Scholar 

  8. Sullivan CE, Issa FG, Berthon-Jones M et al (1981) Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1:862–865 doi:10.1016/S0140-6736(81)92140-1

    Article  PubMed  CAS  Google Scholar 

  9. Farney RJ, Walker JM, Cloward TV (2003) Sleep-disordered breathing associated with long-term opioid therapy. Chest 123:632–639 doi:10.1378/chest.123.2.632

    Article  PubMed  Google Scholar 

  10. Kryger MH, Roth R, Dement WC (2005) Principles and practice of sleep medicine. Elsevier Saunders, Philadelphia

    Google Scholar 

  11. Rechtshaffen A, Kales A (1968) A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. US Department of Health, Education and Welfare, Public Health Service-National Institutes of Health, Neurological Information Network, Bethesda

    Google Scholar 

  12. Santiago TV, Pugliese AC, Edelman NH (1977) Control of breathing during methadone addiction. Am J Med 62:347–354 doi:10.1016/0002-9343(77)90831-2

    Article  PubMed  CAS  Google Scholar 

  13. Teichtahl H, Wang D, Cunnington D (2005) Ventilatory responses to hypoxia and hypercapnia in stable methadone treatment patients. Chest 128:1339–1347 doi:10.1378/chest.128.3.1339

    Article  PubMed  Google Scholar 

  14. Bradly TD (2002) Crossing the threshold: implications for central sleep apnea. Am J Respir Crit Care Med 165:1203–1204 doi:10.1164/rccm.2203016

    Article  Google Scholar 

  15. Skatrud JB, Dempsey JA (1983) Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 55:813–822

    PubMed  CAS  Google Scholar 

  16. Santiago TV, Goldblatt K, Winters K (1980) Respiratory consequences of methadone: the response to added resistance to breathing. Am Rev Respir Dis 122:623–628

    PubMed  CAS  Google Scholar 

  17. Cherniack NS (1981) Respiratory dysrhythmias during sleep. N Engl J Med 305:325–330

    PubMed  CAS  Google Scholar 

  18. Berry RB, Gleeson K (1997) Respiratory arousal from sleep: mechanism and significance. Sleep 20:654–675

    PubMed  CAS  Google Scholar 

  19. Sanders MH, Kern NB (1990) Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Chest 98:317–324 doi:10.1378/chest.98.2.317

    Article  PubMed  CAS  Google Scholar 

  20. Arzt M, Bradly D (2006) Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 173:1300–1308 doi:10.1164/rccm.200511-1745PP

    Article  PubMed  Google Scholar 

  21. Bradley TD, Logan AG, Kimoff RJ (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353:2025–2033 doi:10.1056/NEJMoa051001

    Article  PubMed  CAS  Google Scholar 

  22. Naughton TM, Rahman A, Hara K et al (1995) Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91:1725–1731

    PubMed  CAS  Google Scholar 

  23. Sin DD, Logan AG, Fitzgerald FS et al (2000) Effect of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne–Stokes respiration. Circulation 102:61–66

    PubMed  CAS  Google Scholar 

  24. Goldberg A, Leger P, Hill N, Criner G (1999) Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus conference report. Chest 116:521–534 doi:10.1378/chest.116.2.521

    Article  Google Scholar 

  25. Jones SE, Packham S, Hebden M (1998) Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due severe COPD: long-term follow-up and effect on survival. Thorax 53:495–498

    Article  PubMed  CAS  Google Scholar 

  26. Elliott MW, Simonds AK, Carroll MP (1992) Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due chronic obstructive pulmonary disease; effect on sleep and quality of life. Thorax 47:342–348

    Article  PubMed  CAS  Google Scholar 

  27. Krachman SL, Quaranta AJ, Berger TJ (1997) Effect of noninvasive positive pressure ventilation on gas exchange and sleep in COPD patients. Chest 112:623–628 doi:10.1378/chest.112.3.623

    Article  PubMed  CAS  Google Scholar 

  28. Krachman SL, Minai OA, Scharf SM (2008) Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc 5:536–542 doi:10.1513/pats.200708-134ET

    Article  PubMed  Google Scholar 

  29. Franklin KA, Eriksson P, Sahlin C (1997) Reversal of central sleep apnea with oxygen. Chest 111:163–169 doi:10.1378/chest.111.1.163

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This paper was published in abstract form in the 22nd Annual Meeting of the Associated Professional Sleep Societies.

Conflict of interest

Authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, 685 West Baltimore Street, MSTF 800, Baltimore, MD, 21201-1192, USA

    M. A. Alattar & S. M. Scharf

Authors
  1. M. A. Alattar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. M. Scharf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. M. Scharf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alattar, M.A., Scharf, S.M. Opioid-associated central sleep apnea: a case series. Sleep Breath 13, 201–206 (2009). https://doi.org/10.1007/s11325-008-0221-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-008-0221-7

Keywords

Search

Navigation